Sabaa International Company for Pharmaceutical and Chemical Industry (EGX:SIPC)

EGX:SIPC Balance Sheet

Financials in millions EGP. Fiscal year is January - December.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	2.72	1.94	0.61	0.42	0.15	4.87
Cash & Short-Term Investments	2.72	1.94	0.61	0.42	0.15	4.87
Cash Growth	130.12%	217.85%	44.30%	183.26%	-96.93%	-39.65%
Accounts Receivable	22.57	10.13	4.9	7.95	7.54	11.42
Other Receivables	5.45	0.05	0.05	0.07	0.75	1.62
Receivables	28.02	22.91	13.71	8.99	13.9	13.09
Inventory	41.77	39.81	42.24	50.45	32.3	28.85
Prepaid Expenses	-	-	-	-	0.07	0
Other Current Assets	-	1.39	5.91	2.89	0.12	1.35
Total Current Assets	72.51	66.06	62.47	62.76	46.54	48.15
Property, Plant & Equipment	109.59	102.95	106.28	107.37	109.16	107.46
Other Intangible Assets	-	0.02	0.01	0.22	-	-
Long-Term Deferred Charges	-	-	-	-	0.35	0.38
Other Long-Term Assets	-	-	0	-	-	-
Total Assets	182.1	169.02	168.76	170.35	156.05	155.99

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Accounts Payable	27.97	21.09	22.26	14.16	1.67	1.25
Accrued Expenses	-	2.37	3.43	2.6	2.38	1.83
Short-Term Debt	20.37	16.26	24.26	20.43	0.3	4.04
Current Portion of Long-Term Debt	-	8.19	4.43	4.08	-	-
Current Portion of Leases	-	-	-	0	-	-
Current Income Taxes Payable	3.54	3.54	3.19	3.19	2.89	3.56
Other Current Liabilities	20.11	9.44	10.31	6.05	12.2	9.26
Total Current Liabilities	72	60.9	67.89	50.52	19.44	19.94
Long-Term Debt	-	-	3.69	2.68	20.35	20.25
Long-Term Deferred Tax Liabilities	3.13	2.5	1.64	2.21	1.19	0.24
Total Liabilities	75.13	63.41	73.23	55.4	40.97	40.43

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Common Stock	100	100	100	100	100	100
Retained Earnings	6.97	5.62	-4.47	14.95	15.07	15.56
Shareholders' Equity	106.97	105.62	95.53	114.95	115.07	115.56
Total Liabilities & Equity	182.1	169.02	168.76	170.35	156.05	155.99

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Total Debt	20.37	24.46	32.39	27.19	20.64	24.28
Net Cash (Debt)	-17.65	-22.51	-31.78	-26.76	-20.49	-19.42
Net Cash Growth	-	-	-	-	-	-
Net Cash Per Share	-0.07	-0.09	-0.13	-0.11	-0.08	-0.08
Filing Date Shares Outstanding	242.35	250	250	250	250	250
Total Common Shares Outstanding	242.35	250	250	250	250	250
Working Capital	0.52	5.15	-5.42	12.24	27.1	28.21
Book Value Per Share	0.44	0.42	0.38	0.46	0.46	0.46
Tangible Book Value	106.97	105.6	95.52	114.73	115.07	115.56
Tangible Book Value Per Share	0.44	0.42	0.38	0.46	0.46	0.46
Land	-	7.6	7.6	7.6	7.6	7.6
Buildings	-	111.38	111.38	111.38	110.51	89.72
Machinery	-	22.25	22.24	21.17	19.76	18.62
Construction In Progress	-	0.16	-	-	-	16.49

Data Source: S&P Global Market Intelligence Last updated: Nov 1, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Nov 13, 2026

Data Sources Report a data error